Mouwasat Medical Services Co. (4002) is listed on Tadawul of the Saudi Exchange (Tadawul) under sector Health Care Equipment & Svc. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).

For fiscal year 2025, Mouwasat Medical Services Co. reported revenue of SAR 3.22B, net profit of SAR 822M, and earnings per share of SAR 4.11. Total assets stood at SAR 5.99B with total equity of SAR 3.78B and total liabilities of SAR 2.07B.

Operating cash flow for 2025 was SAR 1.18B, representing a cash conversion ratio of 1.43 relative to net profit. Free cash flow was SAR 502M.

Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2025, SAR 1.43 arrived as operating cash. This indicates Exceptional quality earnings based on the cash conversion ratio of 1.43.

Revenue growth from 2024 to 2025: +11.9%. Net profit growth over the same period: +27.3%. 3-year revenue CAGR: 37.7%. 3-year net profit CAGR: 11.1%.

Key financial ratios for 2025: Return on Equity 21.8%, Return on Assets 13.7%, Net Margin 25.5%, Debt to Equity 0.55.

In 2024, Mouwasat Medical Services Co. reported revenue of SAR 2.88B and net profit of SAR 646M, compared to SAR 3.22B and SAR 822M respectively in 2025.